Induction Healthcare - Directorate Change

Induction Healthcare

09/04/2025 18:15

RNS Number : 3896E

Induction Healthcare Group PLC

09 April 2025

 

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Board Changes

 

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide announces that Andy Williams has submitted his resignation to the Board, stepping down from his position as Non-Executive Director and member of the Audit, Remuneration, and Nomination Committees of the Board with immediate effect.

 

The Board would like to take this opportunity to thank Andy for his contribution to the Company and wish him well for the future.



 

ENQUIRIES

 

Induction Healthcare Group
Christopher Samler, Chair
Paul Tambeau, Chief Executive Officer
+44 (0)7712 194092
+44 (0)7983 104443
Singer Capital Markets (Nominated Adviser and Broker)
+44 (0)20 7496 3000
Philip Davies
Oliver Platts


 

 

About Induction - www.inductionhealthcare.com

 

Induction (AIM: INHC) delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well as non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
BOAUPUCPCUPAGQB